{
  "citations": [
    {
      "id": 7283333,
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "crossReferences": [
        {
          "id": 769250885,
          "resource": "PubMed",
          "resourceId": "21412232",
          "_url": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
          "version": 0
        },
        {
          "id": 1449247827,
          "resource": "DOI",
          "resourceId": "10.1038/clpt.2011.34",
          "_url": "http://dx.doi.org/10.1038%2Fclpt.2011.34",
          "version": 0
        }
      ],
      "hasKeyword": true,
      "journal": "Clinical pharmacology and therapeutics",
      "meshDiseases": [],
      "meshTerms": [
        "Animals",
        "Aryl Hydrocarbon Hydroxylases",
        "Cytochrome P-450 CYP2C9",
        "Drug Administration Schedule",
        "Drug-Related Side Effects and Adverse Reactions",
        "Humans",
        "Pharmaceutical Preparations",
        "Pharmacogenetics",
        "Practice Guidelines as Topic"
      ],
      "month": 5,
      "nonHuman": false,
      "objCls": "Literature",
      "page": "662-73",
      "pediatric": false,
      "pgkbPublication": false,
      "pubDate": "2011-05-01T00:00:00-07:00",
      "summary": "Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics-based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine-S-methyltransferase (TPMT), dihydropyrimidine dehydrogenase (DPD), vitamin K epoxide reductase (VKORC1), uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1), HLA-B44, HLA-B*5701, CYP3A5, and factor V Leiden (FVL).",
      "terms": [],
      "version": 2,
      "volume": "89",
      "year": 2011
    }
  ],
  "guideline": {
    "objCls": "Guideline Annotation",
    "id": "PA166104931",
    "name": "Annotation of DPWG Guideline for esomeprazole and CYP2C19",
    "alternateDrugAvailable": false,
    "cancerGenome": false,
    "crossReferences": [],
    "dosingInformation": false,
    "guidelineGenes": [
      {
        "id": 1451728180,
        "alleles": [],
        "gene": {
          "objCls": "Gene",
          "id": "PA124",
          "symbol": "CYP2C19",
          "name": "cytochrome P450 family 2 subfamily C member 19",
          "alleleFile": "CYP2C19_allele_definition_table.xlsx",
          "altNames": {
            "synonym": [
              "cytochrome P450, family 2, subfamily C, polypeptide 19"
            ],
            "symbol": [
              "CPCJ",
              "CYP2C",
              "P450IIC19"
            ]
          },
          "buildVersion": "GRCh38.p7",
          "cbStart": "q23.33",
          "cbStop": "q23.33",
          "chr": {
            "objCls": "Chromosome",
            "id": "PA504",
            "name": "chr10",
            "version": 3
          },
          "chrStartPosB37": 96522463,
          "chrStartPosB38": 94762681,
          "chrStopPosB37": 96612671,
          "chrStopPosB38": 94853205,
          "cpicGene": true,
          "crossReferences": [
            {
              "id": 553242512,
              "resource": "Comparative Toxicogenomics Database",
              "resourceId": "1557",
              "_url": "http://ctdbase.org/detail.go?type=gene&acc=1557",
              "version": 0
            },
            {
              "id": 132256028,
              "resource": "Ensembl",
              "resourceId": "ENSG00000165841",
              "_url": "https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165841",
              "version": 0
            },
            {
              "id": 73372,
              "resource": "GenAtlas",
              "resourceId": "CYP2C19",
              "_url": "http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=CYP2C19",
              "version": 1
            },
            {
              "id": 88300,
              "resource": "GeneCard",
              "resourceId": "CYP2C19",
              "_url": "https://www.genecards.org/cgi-bin/carddisp.pl?gene=CYP2C19",
              "version": 1
            },
            {
              "id": 608081307,
              "resource": "HGNC",
              "resourceId": "HGNC:2621",
              "_url": "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC%3A2621",
              "version": 1
            },
            {
              "id": 608081309,
              "resource": "HumanCyc Gene",
              "resourceId": "HS09293",
              "_url": "http://biocyc.org/HUMAN/NEW-IMAGE?object=HS09293",
              "version": 0
            },
            {
              "id": 560874113,
              "resource": "ModBase",
              "resourceId": "P33261",
              "_url": "http://salilab.org/modbase/search?modelflag=longest&databaseID=P33261",
              "version": 0
            },
            {
              "id": 455910,
              "resource": "MutDB",
              "resourceId": "CYP2C19",
              "_url": "http://www.mutdb.org/genes/search?_method=POST&data%5BSearch%5D%5Bidentifier%5D=CYP2C19",
              "version": 1
            },
            {
              "id": 10744,
              "resource": "NCBI Gene",
              "resourceId": "1557",
              "_url": "https://www.ncbi.nlm.nih.gov/gene/1557",
              "version": 1
            },
            {
              "id": 716,
              "resource": "OMIM",
              "resourceId": "124020",
              "_url": "https://omim.org/entry/124020",
              "version": 1
            },
            {
              "id": 560556306,
              "resource": "OMIM",
              "resourceId": "609535",
              "_url": "https://omim.org/entry/609535",
              "version": 0
            },
            {
              "id": 1451280335,
              "resource": "PharmVar Gene",
              "resourceId": "CYP2C19",
              "_url": "https://www.pharmvar.org/gene/CYP2C19",
              "version": 0
            },
            {
              "id": 560556305,
              "resource": "RefSeq DNA",
              "resourceId": "NG_008384",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NG_008384",
              "version": 0
            },
            {
              "id": 37037,
              "resource": "RefSeq DNA",
              "resourceId": "NT_030059",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NT_030059",
              "version": 1
            },
            {
              "id": 37896,
              "resource": "RefSeq Protein",
              "resourceId": "NP_000760",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NP_000760",
              "version": 1
            },
            {
              "id": 46971,
              "resource": "RefSeq RNA",
              "resourceId": "NM_000769",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NM_000769",
              "version": 1
            },
            {
              "id": 122288,
              "resource": "UCSC Genome Browser",
              "resourceId": "NM_000769",
              "_url": "https://genome.ucsc.edu/cgi-bin/hgTracks?Submit=Submit&position=NM_000769",
              "version": 1
            },
            {
              "id": 62333091,
              "name": "CP2CJ_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "P33261",
              "_url": "https://www.uniprot.org/uniprot/P33261",
              "version": 1
            },
            {
              "id": 88,
              "resource": "URL",
              "resourceId": "http://www.imm.ki.se/CYPalleles/cyp2c19.htm",
              "_url": "http://www.imm.ki.se/CYPalleles/cyp2c19.htm",
              "version": 1
            }
          ],
          "hasNonStandardHaplotypes": false,
          "hideHaplotypes": false,
          "pharmVarGene": true,
          "strand": "plus",
          "terms": [
            {"id":560498878,"_url":"http://amigo.geneontology.org/amigo/term/GO:0004497","resource":"Gene Ontology","term":"monooxygenase activity","termId":"GO:0004497"},
            {"id":560500134,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005783","resource":"Gene Ontology","term":"endoplasmic reticulum","termId":"GO:0005783"},
            {"id":560500141,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005789","resource":"Gene Ontology","term":"endoplasmic reticulum membrane","termId":"GO:0005789"},
            {"id":560500144,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005792","resource":"Gene Ontology","term":"microsome","termId":"GO:0005792"},
            {"id":560501294,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008202","resource":"Gene Ontology","term":"steroid metabolic process","termId":"GO:0008202"},
            {"id":560496176,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008395","resource":"Gene Ontology","term":"steroid hydroxylase activity","termId":"GO:0008395"},
            {"id":560503412,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009055","resource":"Gene Ontology","term":"electron carrier activity","termId":"GO:0009055"},
            {"id":560499972,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016020","resource":"Gene Ontology","term":"membrane","termId":"GO:0016020"},
            {"id":560506711,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016098","resource":"Gene Ontology","term":"monoterpenoid metabolic process","termId":"GO:0016098"},
            {"id":560495264,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016491","resource":"Gene Ontology","term":"oxidoreductase activity","termId":"GO:0016491"},
            {"id":560507281,"_url":"http://amigo.geneontology.org/amigo/term/GO:0017144","resource":"Gene Ontology","term":"drug metabolic process","termId":"GO:0017144"},
            {"id":560508105,"_url":"http://amigo.geneontology.org/amigo/term/GO:0018675","resource":"Gene Ontology","term":"(S)-limonene 6-monooxygenase activity","termId":"GO:0018675"},
            {"id":560508106,"_url":"http://amigo.geneontology.org/amigo/term/GO:0018676","resource":"Gene Ontology","term":"(S)-limonene 7-monooxygenase activity","termId":"GO:0018676"},
            {"id":560509226,"_url":"http://amigo.geneontology.org/amigo/term/GO:0019825","resource":"Gene Ontology","term":"oxygen binding","termId":"GO:0019825"},
            {"id":560496866,"_url":"http://amigo.geneontology.org/amigo/term/GO:0019899","resource":"Gene Ontology","term":"enzyme binding","termId":"GO:0019899"},
            {"id":560509358,"_url":"http://amigo.geneontology.org/amigo/term/GO:0020037","resource":"Gene Ontology","term":"heme binding","termId":"GO:0020037"},
            {"id":560513624,"_url":"http://amigo.geneontology.org/amigo/term/GO:0033767","resource":"Gene Ontology","term":"4-hydroxyacetophenone monooxygenase activity","termId":"GO:0033767"},
            {"id":560515690,"_url":"http://amigo.geneontology.org/amigo/term/GO:0042738","resource":"Gene Ontology","term":"exogenous drug catabolic process","termId":"GO:0042738"},
            {"id":560495388,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046483","resource":"Gene Ontology","term":"heterocycle metabolic process","termId":"GO:0046483"},
            {"id":560495445,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046872","resource":"Gene Ontology","term":"metal ion binding","termId":"GO:0046872"},
            {"id":560509993,"_url":"http://amigo.geneontology.org/amigo/term/GO:0055114","resource":"Gene Ontology","term":"oxidation reduction","termId":"GO:0055114"}
          ],
          "version": 7209
        },
        "version": 0
      }
    ],
    "hasTestingInfo": false,
    "history": [
      {
        "id": 1183704469,
        "date": "2011-08-10T00:00:00-07:00",
        "type": "Create",
        "version": 0
      },
      {
        "id": 1450414962,
        "date": "2019-05-23T10:35:24.687-07:00",
        "description": "Annotation current with November 2018 DPWG Guideline release",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450820627,
        "date": "2019-10-03T09:52:08.418-07:00",
        "description": "No changes based on August 2019 guideline",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1450956346,
        "date": "2020-01-31T13:29:18.686-08:00",
        "description": "Updated link to 2011 DPWG methods",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450962960,
        "date": "2020-02-10T11:44:10.253-08:00",
        "description": "Fixed links to 2018 guideline pdfs.",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451704186,
        "date": "2022-03-03T16:33:23.944-08:00",
        "description": "Annotation current with May 2021 DPWG Guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451706321,
        "date": "2022-03-07T16:42:25.245-08:00",
        "description": "Corrected typo",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451732826,
        "date": "2022-03-28T09:57:37.561-07:00",
        "description": "Annotation current with February 2022 DPWG guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451884235,
        "date": "2022-09-16T10:10:04.958-07:00",
        "description": "Fixed link to gene information document and added explanatory note",
        "type": "Update",
        "version": 0
      }
    ],
    "literature": [
      {"id":7283333,"title":"Pharmacogenetics: from bench to byte--an update of guidelines.","_sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/21412232","crossReferences":[{"id":769250885,"resource":"PubMed","resourceId":"21412232","_url":"https://www.ncbi.nlm.nih.gov/pubmed/21412232"},{"id":1449247827,"resource":"DOI","resourceId":"10.1038/clpt.2011.34","_url":"http://dx.doi.org/10.1038%2Fclpt.2011.34"}],"objCls":"Literature","terms":[]},
      {"id":15103288,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2019","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","crossReferences":[{"id":1450815695,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf"}],"objCls":"Literature","terms":[]},
      {"id":15102465,"title":"Dutch Pharmacogenetics Working Group Guidelines November 2018","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","crossReferences":[{"id":1450415575,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf"}],"objCls":"Literature","terms":[]}
    ],
    "pediatric": false,
    "recommendation": false,
    "relatedAlleles": [],
    "relatedChemicals": [
      {
        "objCls": "Chemical",
        "id": "PA10075",
        "name": "esomeprazole",
        "version": 15
      }
    ],
    "relatedGenes": [
      {
        "objCls": "Gene",
        "id": "PA124",
        "symbol": "CYP2C19",
        "name": "cytochrome P450 family 2 subfamily C member 19",
        "version": 7209
      }
    ],
    "source": "DPWG",
    "summaryMarkdown": {
      "id": 1447981838,
      "html": "<p>No action is needed for this gene-drug interaction.</p>\n",
      "version": 1
    },
    "terms": [],
    "textMarkdown": {
      "id": 1447981837,
      "html": "<h3 id=\"november-2018-update\">November 2018 Update</h3>\n<p><em><strong>IMPORTANT: As of March 2022, gene information documents from the DPWG are no longer publicly available from the KNMP website. PharmGKB is currently providing PDF versions of these documents to users. These files were downloaded in February 2022. As such, we cannot guarantee that these documents match the mappings DPWG may use internally as there have been no publicly accessible updates since February 2022.</strong></em></p>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for esomeprazole based on CYP2C19 genotype. They conclude that no action is needed for this gene-drug interaction. Although genetic variation leads to higher plasma concentrations or faster inactivation of esomeprazole, there is insufficient evidence to support an effect on the therapeutic effectiveness and side effects (see the <a download=\"DPWG_November_2018.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_November_2018.pdf\">Dutch guidelines November 2018 update</a>).</p>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001824.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a download=\"CYP2C19.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/CYP2C19.pdf\">Read about gene information from DPWG</a></p>\n<h3 id=\"2011-guideline\">2011 Guideline</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for esomeprazole based on <em>CYP2C19</em> genotype [Article:<a href=\"/pmid/21412232\">21412232</a>].  For the <em>CYP2C19</em> UM phenotype, they conclude to be extra alert to insufficient response and recommend to consider dose increase by 50-100%.</p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Phenotype (Genotype)</th>\n<th>Therapeutic Dose Recommendation</th>\n<th>Level of Evidence</th>\n<th>Clinical Relevance</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td><em>CYP2C19</em> PM (*2/*2, *2/*3, *3/*3)</td>\n<td>None</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints</td>\n<td>Positive clinical effects</td>\n</tr>\n<tr>\n<td><em>CYP2C19</em> IM (*1/*2, *1/*3, *17/*2, *17/*3)</td>\n<td>None</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints</td>\n<td>Positive clinical effects</td>\n</tr>\n<tr>\n<td><em>CYP2C19</em> UM (*17/*17)</td>\n<td>Helicobacter pylori eradication: increase dose by 50-100%. Be extra alert to insufficient response. Other: be extra alert to insufficient response. Consider dose increase by 50-100%</td>\n<td>no data was retrieved with the literature search</td>\n<td>no data was retrieved with the literature search</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>*See <a href=\"http://www.pharmgkb.org/page/dpwg\">Methods </a> or [Article:<a href=\"/pmid/18253145\">18253145</a>] for definition of &quot;good quality.&quot;</li>\n</ul>\n",
      "version": 14
    },
    "userId": "jmbarbarino",
    "version": 26
  }
}